Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma

Published:2017-06 Issue:3 Volume:10 Page:304-310
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Jang Jiryeon^ORCID,Rath Oliver,Schueler Julia,Sung Hyun Hwan,Jeon Hwang Gyun,Jeong Byong Chang,Seo Seong Il,Jeon Seong Soo,Lee Hyun Moo,Choi Han-Yong,Kwon Ghee-Young,Park Woong Yang,Lee Jeeyun,Park Se Hoon^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence;Hutson;Oncologist,2011

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

4. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

5. The use of xenograft models for the selection of cancer treatments with the EGFR as an example;Troiani;Crit Rev Oncol Hematol,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study;Current Oncology;2023-10-11

2. Advances in Renal Cell Carcinoma Drug Resistance Models;Frontiers in Oncology;2022-05-10

3. Patient-derived xenograft models to optimize kidney cancer therapies;Translational Andrology and Urology;2019-05

4. Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer;Disease Markers;2017-12-28